Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 171
- Registration Number
- NCT02097056
Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 101
- Registration Number
- NCT01961544
- Locations
- π°π·
Dong-A University Hospital, Busan, Korea, Republic of
π°π·Gachon University Gil Medical Center, Incheon, Korea, Republic of
π°π·Ajou University Hospital, Suwon, Gyeonggi-do, Korea, Republic of
Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 121
- Registration Number
- NCT01140867
- Locations
- π°π·
Kangdong Sacred Heart Hosp., Dept. of Neurology, Seoul, Korea, Republic of
π°π·Bundang CHA Hospital, Dept. of Neurology, Seongnam, Korea, Republic of
π°π·Dong-A University Hospital, Dept. of Neurology, Busan, Korea, Republic of
Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT01127256
- Locations
- π°π·
Seoul National Univ. Bundang Hosp., Bundang, Korea, Republic of
π°π·Dongguk Univ. Ilsan Hosp., Ilsan, Korea, Republic of
π°π·Boramae Medical Center, Seoul, Korea, Republic of
Low and High Dose Zonisamide in Children as Monotherapy
- Conditions
- Interventions
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT01127165
- Locations
- π°π·
Korea Univ. Guro Hospital, Seoul, Korea, Republic of
π°π·Dongsan Medical Center of Keimyung Univ., Seoul, Korea, Republic of
π°π·Inje Univ. Ilsan-Paik Hospital, Seoul, Korea, Republic of
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
- First Posted Date
- 2006-09-27
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 199
- Registration Number
- NCT00381381
- Locations
- π°π·
Seoul National University Bundang Hospital, Bundang, Korea, Republic of
π°π·Jeonju City Welfare Hospital, Jeonju, Korea, Republic of
π°π·Hallym University Medical Center, Changwon, Korea, Republic of
Alzheimer's Disease Long-term Follow-up Study (ALF Study)
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2021-12-30
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT00165724
- Locations
- π°π·
Yeungnam University Hospital, Daegu, Korea, Republic of
π°π·Changwon Fatima Hospital, Changwon, Korea, Republic of
π°π·Bobath Memorial Hospital, Bundang, Korea, Republic of
Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00165750
- Locations
- π°π·
Cheonnam University Hospital, Gwangju, Korea, Republic of
A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-09-02
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT00154076
- Locations
- π°π·
Daegu Catholic University Medical Center, Daegu, Korea, Republic of